COVID-19 – Indonesia to produce three variants of therapeutic drugs
Jakarta (Indonesia Window) – Indonesian pharmaceutical producer and distributor Kimia Farma is producing and distributing three variants of therapeutic drugs to...
Indonesia Window
08 July 2021
COVID-19 – Indonesia to produce antiviral Molnupiravir in April 2022
Jakarta (Indonesia Window) – The Indonesian Health Ministry in collaboration with PT Amarox Pharma Global will produce antiviral Molnupiravir in the country for...
15 January 2022
COVID-19 – Indonesia issues emergency use authorization for Molnupiravir antivirus
Jakarta (Indonesia Window) – Indonesia’s National Agency of Drug and Food Control (BPOM) has issued an emergency use authorization (EUA) for the COVID-19 antivi...
COVID-19 – Four antiviral drugs get emergency use in Indonesia
"The four drugs are Favipiravir, Remdesivir, Regdanvimab and Molnupiravir." Jakarta (Indonesia Window) – Currently, there are four types of drugs that have rece...
01 July 2022
COVID-19 – Indonesia issues EUA for Paxlovid as medicine
"The recommended dose is 300 mg Nirmatrelvir (two 150 mg tablets) with 100 mg Ritonavir (one 100 mg tablet) taken together twice a day for five days." Jakarta (...
18 July 2022
Indonesia has great potentials in developing drugs from natural resources
“The COVID-19 pandemic has become a momentum in encouraging many research and development initiatives, both on drugs and vaccines, which aim to treat and preven...
26 August 2022
